Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Ellison Institute CEO David Agus tells LA Health Commission AI can speed diagnoses, drug design and expand access
Summary
Dr. David Agus told the Los Angeles Health Commission that artificial intelligence is accelerating drug discovery, enabling faster diagnostics and could democratize care by making complex imaging and records analysis cheaper and more widely available; commissioners pressed on bias, security and potential worker impacts.
Dr. David Agus, CEO of the Ellison Medical Institute and a physician, told the Los Angeles Health Commission that artificial intelligence is already shortening drug-development timelines and helping clinicians make faster diagnoses.
“It's a crazy time in our space,” Agus said, describing AI-driven drug discovery and an instance in which image analysis and genetic inference allowed a patient to go home on a targeted pill the day after presenting with a seizure. He cited an observational analysis by Kaiser that, according to his presentation, associated shingles vaccination with more than a 50 percent reduction in Alzheimer’s incidence in people over age 50, and noted multiple non-randomized studies that point to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
